Mismatch Repair Deficiency in Ovarian Carcinoma Frequency, Causes, and Consequences

被引:45
|
作者
Leskela, Susanna [1 ,2 ]
Romero, Ignacio [5 ]
Cristobal, Eva [1 ]
Perez-Mies, Belen [2 ]
Rosa-Rosa, Juan M. [1 ,2 ]
Gutierrez-Pecharroman, Ana
Caniego-Casas, Tamara [1 ]
Santon, Almudena [2 ]
Ojeda, Belen [8 ]
Lopez-Reig, Raquel [6 ]
Palacios-Berraquero, Maria L. [10 ]
Garcia, Angel [9 ]
Ibarra, Javier [12 ]
Hakim, Sofia [13 ]
Guarch, Rosa [11 ]
Lopez-Guerrero, Jose A. [6 ]
Poveda, Andres [7 ]
Palacios, Jose [1 ,2 ,3 ,4 ]
机构
[1] Univ Alcala Henares, Inst Ramon y Cajal Hlth Res, Madrid, Spain
[2] Univ Alcala Henares, Carlos III Hlth Inst, CIBER ONC, Madrid, Spain
[3] Univ Alcala Henares, Hosp Ramon y Cajal, Dept Pathol, Madrid, Spain
[4] Univ Alcala Henares, Fac Med, Madrid, Spain
[5] Hosp Quironsalud Valencia, Clin Area Gynecol Oncol, Valencia, Spain
[6] Hosp Quironsalud Valencia, Valencian Inst Oncol, Lab Mol Biol, Valencia, Spain
[7] Hosp Quironsalud Valencia, Oncogynecol Dept, Initia Oncol, Valencia, Spain
[8] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
[9] Hosp Univ Vall Hebron, Dept Pathol, Barcelona, Spain
[10] Univ Navarra, Dept Hematol & Hemotherapy, Pamplona, Spain
[11] Hosp Navarra, Dept Pathol, Pamplona, Spain
[12] Hosp Son Llatzer, Dept Pathol, Palma de Mallorca, Spain
[13] Hosp Miguel Servet, Dept Pathol, Zaragoza, Spain
关键词
ovarian carcinoma; mismatch repair deficiency; Lynch syndrome; methylation; NGS; mutation; tumor-infiltrating lymphocytes; MOLECULAR-BASED CLASSIFICATION; LYNCH SYNDROME; MICROSATELLITE INSTABILITY; ENDOMETRIOID CARCINOMA; PROTEIN DEFECTS; EARLY-ONSET; CANCER; MUTATIONS; AGE; EXPRESSION;
D O I
10.1097/PAS.0000000000001432
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mismatch repair deficiency (MMRD) is involved in the initiation of both hereditary and sporadic tumors. MMRD has been extensively studied in colorectal cancer and endometrial cancer, but not so in other tumors, such as ovarian carcinoma. We have determined the expression of mismatch repair proteins in a large cohort of 502 early-stage epithelial ovarian carcinoma entailing all the 5 main subtypes: high-grade serous carcinoma, endometrioid ovarian carcinoma (EOC), clear cell carcinoma (CCC), mucinous carcinoma, and low-grade serous carcinoma. We studied the association of MMRD with clinicopathologic and immunohistochemical features, including tumor-infiltrating lymphocytes in EOC, the histologic type in which MMRD is most frequent. In addition, MLH1 promoter methylation status and massive parallel sequencing were used to evaluate the proportion of sporadic and Lynch syndrome-associated tumors, and the most frequently mutated genes in MMRD EOCs. MMRD occurred only in endometriosis-associated histologic types, and it was much more frequent in EOC (18%) than in CCC (2%). The most frequent immunohistochemical pattern was loss of MLH1/PMS2, and in this group, 80% of the cases were sporadic and secondary to MLH1 promoter hypermethylation. The presence of somatic mutations in mismatch repair genes was the other mechanism of MMRD in sporadic tumors. In this series, the minimum estimated frequency of Lynch syndrome was 35% and it was due to germline mutations in MLH1, MSH2, and MSH6. ARID1A, PTEN, KTM2B, and PIK3CA were the most common mutated genes in this series. Interestingly, possible actionable mutations in ERRB2 were found in 5 tumors, but no TP53 mutations were detected. MMRD was associated with younger age and increased tumor-infiltrating lymphocytes. Universal screening in EOC and mixed EOC/CCC is recommended for the high frequency of MMRD detected; however, for CCC, additional clinical and pathologic criteria should be evaluated to help select cases for analysis.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 50 条
  • [1] Frequency of mismatch repair deficiency in ovarian cancer: a systematic review
    Murphy, Megan A.
    Wentzensen, Nicolas
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (08) : 1914 - 1922
  • [2] The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
    Shuang Ye
    Shuling Zhou
    Siyuan Zhong
    Boer Shan
    Wenhua Jiang
    Wentao Yang
    Xu Cai
    Huijuan Yang
    [J]. BMC Cancer, 22
  • [3] The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
    Ye, Shuang
    Zhou, Shuling
    Zhong, Siyuan
    Shan, Boer
    Jiang, Wenhua
    Yang, Wentao
    Cai, Xu
    Yang, Huijuan
    [J]. BMC CANCER, 2022, 22 (01)
  • [4] Clinical features and frequency of mismatch repair protein deficiency in ovarian clear cell and endometrioid carcinoma patients
    Takehara, K.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 425 - 425
  • [5] Mismatch repair deficiency is implicated in carcinoma arising from ovarian teratoma
    Cheung, Alvin Ho-Kwan
    Chow, Chit
    Yu, Mei-Yung
    Law, Wendy Wai-Tak
    Law, Peggy Pui-Ying
    Choi, Paul Cheung-Lung
    Kang, Wei
    To, Ka-Fai
    [J]. PATHOLOGY, 2019, 51 (01) : 67 - 73
  • [6] Mismatch repair deficiency in ovarian cancer
    Fuh, Katherine
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2022, 41
  • [7] Relevance of mismatch repair deficiency in ovarian cancer
    Cicek, Mine S.
    Fridley, Brooke L.
    Rumilla, Kandelaria M.
    Lindor, Noralane M.
    Block, Matthew S.
    Song, Honglin
    Pharoah, Paul
    Sellers, Thomas A.
    Goode, Ellen L.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Mismatch repair deficiency in sporadic ovarian cancers
    任舒月
    杨滨
    任常山
    [J]. ChineseMedicalJournal, 1998, (10)
  • [9] Mismatch repair deficiency in sporadic ovarian cancers
    任舒月
    杨滨
    任常山
    [J]. 中华医学杂志(英文版), 1998, (10) : 16 - 16
  • [10] Mismatch repair deficiency in sporadic ovarian cancers
    Ren, SY
    Yang, B
    Ren, CS
    [J]. CHINESE MEDICAL JOURNAL, 1998, 111 (10) : 880 - 880